Published in Hepatogastroenterology on May 17, 2004
New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol (2006) 1.17
A transgenic model for conditional induction and rescue of portal hypertension reveals a role of VEGF-mediated regulation of sinusoidal fenestrations. PLoS One (2011) 0.91
Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients. BMC Gastroenterol (2011) 0.84
Von Willebrand factor protects against acute CCl4-induced hepatotoxicity through phospho-p38 MAPK signaling pathway inhibition. Immunol Res (2017) 0.75
Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med (1985) 2.84
Possible association between Behçet's syndrome and chronic hepatitis C virus infection. N Engl J Med (1995) 2.83
Genetic characterization of six parasitic protozoa: parity between random-primer DNA typing and multilocus enzyme electrophoresis. Proc Natl Acad Sci U S A (1993) 2.36
Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology (1999) 2.30
Falsely negative 99mTc-antigranulocyte immunoscintigraphy and positive 99mTc-HMPAO-labelled leukocyte scan in active Crohn's disease. Possible effects of immunosuppressive therapy? Nuklearmedizin (1995) 2.00
Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol (1999) 1.89
Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vitro. Gastroenterology (1992) 1.78
Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology (1998) 1.65
Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol (2000) 1.55
CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am J Pathol (1997) 1.51
A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Transplantation (2001) 1.51
Functional spectrum of sinusoidal endothelial liver cells. Filtration, endocytosis, synthetic capacities and intercellular communication. J Hepatol (1992) 1.51
Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology (1997) 1.49
Clearance of HCV RNA in a chronic hepatitis C virus-infected patient during acute hepatitis B virus superinfection. Liver (1999) 1.49
Role of the thymus in transplantation tolerance in miniature swine. I. Requirement of the thymus for rapid and stable induction of tolerance to class I-mismatched renal allografts. J Exp Med (1997) 1.44
Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair. Histochem Cell Biol (1999) 1.43
Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia. J Hepatol (1997) 1.42
[Initial clinical experiences with TIPS (transjugular intrahepatic portasystemic stent-shunt)]. Leber Magen Darm (1995) 1.40
[Current theraphy of oesophageal cancer]. Z Gastroenterol (2004) 1.39
[Portal hypertension--pathophysiology and therapeutic approaches]. Z Gastroenterol (1994) 1.38
Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol (2000) 1.36
Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J Immunol (1985) 1.33
Accumulation and cellular localization of fibrinogen/fibrin during short-term and long-term rat liver injury. Gastroenterology (1995) 1.32
Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology (1999) 1.27
The IGF axis and hepatocarcinogenesis. Mol Pathol (2001) 1.26
Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column. Transplantation (1998) 1.23
Glial fibrillary acidic protein--a cell type specific marker for Ito cells in vivo and in vitro. J Hepatol (1996) 1.23
Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum. Acta Diabetol (1997) 1.19
Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. Am J Pathol (1999) 1.18
Gastrointestinal pH profiles in patients with inflammatory bowel disease. Aliment Pharmacol Ther (1998) 1.17
Transforming growth factor beta 1-regulated gene expression of Ito cells. Hepatology (1996) 1.17
Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. J Virol (2001) 1.17
Fat storing cells (FSC) of rat liver synthesize and secrete fibronectin. Comparison with hepatocytes. J Hepatol (1987) 1.17
The bcl, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells. Eur J Cell Biol (2001) 1.09
Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron. Pain (1995) 1.09
Cell-type-specific expression of neural cell adhesion molecule (N-CAM) in Ito cells of rat liver. Up-regulation during in vitro activation and in hepatic tissue repair. Am J Pathol (1996) 1.08
Update of current immunosuppressive drugs used in clinical organ transplantation. Transpl Int (1998) 1.07
Dementia and driving. J R Soc Med (1992) 1.04
Localization and mRNA steady-state level of cellular fibronectin in rat liver undergoing a CCl4-induced acute damage or fibrosis. Biochim Biophys Acta (1993) 1.03
Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs). J Pathol (2008) 1.03
The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is downregulated during cell growth and by transforming growth factor-beta. Biochem Biophys Res Commun (1992) 1.03
Liver fibrosis and altered matrix synthesis. Can J Gastroenterol (2001) 1.03
Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate. Biochem J (2000) 1.02
Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC). Carcinogenesis (1998) 1.02
Intercellular adhesion molecule-1 concentration in sera of patients with acute and chronic liver disease: relationship to disease activity and cirrhosis. Hepatology (1993) 1.01
Epidural spinal electrical stimulation for severe angina: a study of its effects on symptoms, exercise tolerance and degree of ischaemia. Eur Heart J (1992) 1.01
Characterization of a monoclonal anti-porcine CD3 antibody. Xenotransplantation (1999) 1.01
Carbohydrate metabolism and the liver: actual aspects from physiology and disease. Z Gastroenterol (2007) 1.01
Mechanism of cyclosporin-induced tolerance to primarily vascularized allografts in miniature swine. Effect of administration of exogenous IL-2. J Immunol (1994) 0.99
Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines. Gastroenterology (1992) 0.99
Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.99
Bone morphogenetic protein-6 is expressed in nonparenchymal liver cells and upregulated by transforming growth factor-beta 1. Exp Cell Res (1997) 0.99
Presence of melatonin in the human hepatobiliary-gastrointestinal tract. Life Sci (2001) 0.98
Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis. Am J Clin Pathol (2001) 0.98
Effect of tumour necrosis factor-alpha on proliferation, activation and protein synthesis of rat hepatic stellate cells. J Hepatol (1997) 0.98
Guillain-Barré syndrome and human diploid cell rabies vaccine. Lancet (1989) 0.97
Gene expression and regulation of plasminogen activator inhibitor type I in hepatic stellate cells of rat liver. Gastroenterology (1996) 0.97
Decrease of platelet-endothelial cell adhesion molecule 1-gene-expression in inflammatory cells and in endothelial cells in the rat liver following CCl(4)-administration and in vitro after treatment with TNFalpha. Immunol Lett (2000) 0.97
Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats. Lab Invest (2000) 0.96
Two management policies for patients after myocardial infarction: Does exercise testing and a more intensive approach make any difference? BMJ (1989) 0.96
HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication? World J Gastroenterol (2001) 0.95
Inflammation, damage repair and liver fibrosis--role of cytokines and different cell types. Z Gastroenterol (2007) 0.95
Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis. Eur J Immunol (1988) 0.95
Characterization of the IGF axis components in isolated rat hepatic stellate cells. Hepatology (1998) 0.94
Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy. World J Gastroenterol (2001) 0.94
Carcinosarcoma of the liver. Histopathology (1998) 0.94
Quantitative determination of complement components produced by purified hepatocytes. Clin Exp Immunol (1984) 0.94
Situs inversus of donor or recipient in liver transplantation. Transpl Int (1998) 0.94
Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease. J Hepatol (1996) 0.94
Sinusoidal endothelial liver cells in vitro release endothelin--augmentation by transforming growth factor beta and Kupffer cell-conditioned media. Klin Wochenschr (1991) 0.93
Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases. Int J Colorectal Dis (2008) 0.93
Tolerance to class I-disparate renal allografts in miniature swine. Maintenance of tolerance despite induction of specific antidonor CTL responses. Transplantation (1995) 0.93
Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury. Hepatology (1997) 0.93
Preferential virological response to interferon-alpha 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low gamma-GT/ALT ratio. Dig Dis Sci (1996) 0.93
Role of the thymus in transplantation tolerance in miniature swine: II. Effect of steroids and age on the induction of tolerance to class I mismatched renal allografts. Transplantation (1999) 0.92
The homeobox transcription factor Prox1 is highly conserved in embryonic hepatoblasts and in adult and transformed hepatocytes, but is absent from bile duct epithelium. Anat Embryol (Berl) (2004) 0.92
High inflammatory activity is associated with an increased amount of IFN-gamma transcripts in peripheral blood cells of patients with chronic hepatitis C virus infection. Med Microbiol Immunol (1996) 0.92
Hepatocellular clearance function of bacterial lipopolysaccharides and free lipid A in mice with endotoxic shock. Am J Emerg Med (1984) 0.92
Cellular localization of hepatic cytochrome 1B1 expression and its regulation by aromatic hydrocarbons and inflammatory cytokines. Biochem Pharmacol (1999) 0.91
Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy. J Hepatol (1998) 0.90
Glucocorticoid receptor signaling in the intestinal epithelial cell lines IEC-6 and Caco-2: evidence of inhibition by interleukin-1beta. Int J Colorectal Dis (2001) 0.90
Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question. Gastroenterology (2004) 0.90
Induction of tolerance to renal allografts across single-haplotype MHC disparities in miniature swine. Transplantation (1995) 0.90
Autoreceptors can modulate 5-hydroxytryptamine release from porcine and human small intestine in vitro. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.90